.jpg "Oliver Eng, MD photo")
Associate Professor of Surgery
University of California, Irvine
Oliver Eng, MD, FACS, FSSO, is a surgical oncologist and an Associate Professor in the Division of Surgical Oncology at the University of California, Irvine, where he is Associate Director of the Peritoneal Surface Malignancy Program and the Complex General Surgical Oncology Fellowship, as well as Co-Director of the Surgery Clerkship. He is a double board-certified surgeon and surgical oncologist who focuses on the treatment of peritoneal metastases and in complex cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). Dr. Eng has co-authored numerous peer-reviewed publications and has received extramural funding for his research, which centers on better understanding the molecular and immunologic characteristics of peritoneal tumors. His research aims to develop innovative therapies for metastatic disease and optimize outcomes and care in cancer patients. He has been appointed to a number of national committees, and is a member of the American Board of Surgery Complex General Surgical Oncology Board. He is a principal investigator or co-investigator on multiple clinical trials and serves on the editorial board for a variety of scientific journals.